Cutaneous and transdermal delivery-processes and systems of delivery

Modern Pharmaceutics, Fourth Edition, Revised and Expanded

Volumn , Issue , 2002, Pages 293-363

  Flynn, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878655390     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. A.P. Lemberger, in Handbook of Non-Prescription Drugs, American Pharmaceutical Association, Washington, DC, 1973, p. 161.
2. G.L. Wilkes, I.A. Brown, and R.H. Wildnauer, CRC Crit. Rev. Bioeng., Aug., 453 (1973).
3. K.F. Rushmer, K.J.K. Buettner, J.M. Short, and G.F. Odland, Science, 154, 343 (1966).
4. R.J. Scheuplein and I.H. Blank, Physiol. Rev., 51, 762 (1971).
5. W. Montagna, The Structure and Function of Skin, 3rd ed., Academic Press, New York, 1974.
6. P.M. Elias, S. Grayson, M.A. Lampe, M.L. Williams, and B.E. Brown, in Stratum Corneum (R. Marks and G. Plewig, eds.), Springer-Verlag, New York, 1983, pp. 53-67.
7. J.W. Tingstad, D.E. Wurster, and T. Higuchi, J. Am. Pharm. Assoc., 47, 187 (1958).
8. R.J. Scheuplein, J. Invest. Dermatol., 47, 334 (1965).
9. H. Baker and A.M. Kligman, Arch. Dermatol., 96, 441 (1967).
10. R.J. Scheuplein, J. Invest. Dermatol., 48, 79 (1967).
11. R.T. Woodburne, Essentials of Human Anatomy, Oxford University Press, New York, 1965, p.6.
12. S. Rothman, Physiology and Biochemistry of the Skin, University of Chicago Press, Chicago, 1954, p. 26.
13. A.E. McKenzie, Arch. Dermatol., 86, 611 (1962).
14. R.B. Stoughton, Southern Med. J., 55, 1134 (1962).
15. G. Sazbo, Adv. Biol. Skin, 3, 1 (1962).
16. M. Katz and B.J. Poulsen, in Handbook of Experimental Pharmacology, New Series, Vol. 28 (B.B. Brodie and J. Gillette, eds.), Springer-Verlag, New York, 1972, p. 103.
17. S.M. Peck and W.R. Russ, Arch. Dermatol. Syphilol., 56, 601 (1947).
18. M.R. Liggins, Patient Care, July 1, 56 (1974).
19. B. Idson, J. Soc. Cosmet. Chem., 24, 1972 (1973).
20. K. Laden, Am.Perfum. Cosmet., 82, 77 (1967).
21. J.N. Robinson, in Handbook of Non-Prescription Drugs, American Pharmaceutical Association, Washington, DC, 1973, p. 209.
22. R.B. Stoughton, Clin. Pharmacol. Ther., 16, 869 (1974).
23. J.J. Voorhees, E.A. Duell, M. Stawiski, and E.R. Harrell, Clin. Pharmacol. Ther., 16, 919 (1973).
24. W.R. Good, Med. Device Diag. Ind., Feb., 35 (1986).
25. G.W. Cleary, in Medical Applications of Controlled Release, Vol. 1 (R.S. Langer and D.L. Wise eds.), CRC Press, Boca Raton, FL, 1983, pp. 203-251.
26. Y.W. Chien, Novel Drug Delivery Systems, Marcel Dekker, New York, 1982, pp. 149-217.
27. J.P. Marty, R.H. Guy, and H.I. Maibach, Percutaneous Absorption, 2nd ed. (R.L. Bronaugh and H.I. Maibach, eds.), Marcel Dekker, New York, 1989, pp. 511-529.
28. C.R. Behl, N.H. Bellantone, and G.L. Flynn, in Percutaneous Absorption (R.L. Bronaugh and H.I. Maibach, eds.), Marcel Dekker, New York, 1985, pp. 183-212.
29. L.B. Fisher, in Percutaneous Absorption, 2nd ed. (R.L. Bronaugh and H.I. Maibach, eds.), Marcel Dekker, New York, 1989, pp. 213-222.
30. D.A. Weingand, C. Haygood, J.R. Gaylor, and J.H. Anglin, Jr., in Current Concepts in Cutaneous Toxicity (V.A. Drill and P. Lazar, eds.), Academic Press, New York, 1980, pp. 221-235.
31. D.A. Weingand, C. Haygood, and J.R. Gaylor, J. Invest. Dermatol., 62, 563 (1974).
32. H.H. Durrheim, G.L. Flynn, W.I. Higuchi, and C.R. Behl, J. Pharm. Sci., 69, 781 (1980).
33. G.L. Flynn, E.E. Linn, T. Kurihara-Bergstrom, S.K. Govil, and S.Y.E. Hou, in Transdermal Delivery of Drugs, Vol. 2, CRC Press, Boca Raton, FL, 1987.
34. C.G.T. Mathias, in Dermatotoxicology, 2nd ed. (F.N. Marzulli and H.I. Maibach, eds.), Hemisphere Publishing, New York, 1983, pp. 167-183.
35. M.S. Roberts, A.A. Anderson, J. Swarbrik, and D.E. Moore, J. Pharm. Pharmacol., 30, 486 (1978).
36. H.P. Bader, L.A. Goldsmith, and L. Bonar, J. Invest. Dermatol., 60, 215 (1971).
37. J.A. Keipert, Med. J. Aust., 1, 1021 (1971).
38. G.L. Flynn, in Percutaneous Absorption: Mechanism-Methodology-Drug Delivery, 2nd ed. (R. Bronaugh and H.I. Maibach, eds.), Marcel Dekker, New York, 1989, pp. 27-51.
39. G.L. Flynn, S.H. Yalkowsky, and T.J. Roscman, J. Pharm. Sci., 63, 479 (1974).
40. R.J. Scheuplein and R.L. Bronaugh, in Biochemistry and Physiology of the Skin, Vol. 2 (L.A. Goldsmith, ed.), Oxford University Press, New York, 1983, pp. 1255-1295.
41. T. Higuchi and S.S. Davis, J. Pharm. Sci., 59, 1376 (1970).
42. S.S. Davis, T. Higuchi, and J.H. Rytting, Adv. Pharm. Sci., 4, 73 (1974).
43. R.J. Scheuplein, I.H. Blank, G.J. Brauner, and D.J. MacFarlane, J. Invest. Dermatol., 52, 63 (1969).
44. G.L. Flynn, in Principles of Route-to-Route Extrapolation for Risk Assessment (T.R. Gerrity and C.J. Henry, eds.), Elsevier, New York, 1990, pp. 93-128.
45. R.O. Potts and R.H. Guy, Pharm. Res., 9, 663 (1992).
46. N.Z. Erdi, M.M. Cruz, and O.A. Battista, J. Colloid Interface Sci., 28, 36 (1968).
47. P. Thau and C. Fox, J. Soc. Cosmet. Chem., 16, 359 (1965).
48. S. Foster, D.E. Wurster, T. Higuchi, and L.W. Busse, J. Am. Pharm. Assoc. (Sci. Ed.), 40, 123 (1951).
49. B.W. Barry, J. Pharm. Pharmacol., 21, 533 (1969).
50. S. Amott, A. Fulmer, W.E. Scott, I.C.M. Dea, R. Moorhouse, and D.A. Rees, J. Mol. Biol., 90, 269 (1974).
51. Physician’s Desk Reference, 28th ed., Medical Economics, Oradell, NJ, 1974, p. 1460.
52. G.L. Flynn and T.J. Roseman, J. Pharm. Sci., 60, 1778 (1971).
53. G.L. Flynn, J. Pharm. Sci., 60, 345 (1971).
54. T.A. Hagen, Physicochemical Study of Hydrocortisone and Hydrocortisone n-Alkyl-21-Esters, thesis, University of Michigan, 1979.
55. W.M. Smith, An Inquiry into the Mechanism of Percutaneous Absorption of Hydrocortisone and its n-Alkyl Esters, thesis, University of Michigan, 1982.
56. C.A. Schlagel, Adv. Biol. Skin, 12, 339 (1972).
57. A.W. McKenzie and R.M. Atkinson, Arch. Dermatol., 89, 741 (1964).
58. G. Saracco and B. Spaccamella-Marcheti, Ann. Chem., 48, 1357 (1958).
59. S.H. Yalkowsky, G.L. Flynn, and T.G. Slunick, J. Pharm. Sci., 61, 852 (1972).
60. G.L. Flynn and S.H. Yalkowsky, J. Pharm. Sci., 61, 838 (1972).
61. D.E. Wurster, Am. Perfum. Cosmet., 80, 21 (1965).
62. T. Higuchi, J. Soc. Cosmet. Chem., 11, 85 (1960).
63. K.H. Burdick, B.J. Poulsen, and V.A. Place, JAMA, 211,462(1970).
64. H. Schaefer and T.E. Redelmeier, Skin Barrier-Principles of Percutaneous Absorption, Karger, Basel, 1996, pp. 213-223.
65. A.W. McKenzie and R.B. Stoughton, Arch. Dermatol., 86, 608 (1962).
66. C.F.H. Vickers, Adv. Biol. Skin, 12, 177 (1972).
67. R.B. Stoughton, Arch. Dermatol., 91, 657 (1965).
68. R.J. Scheuplein and L. Ross, J. Soc. Cosmet. Chem., 21, 853 (1970).
69. S.G. Elfbaum and K. Laden, J. Soc. Cosmet. Chem., 19, 163 (1968).
70. R. Jones, Excipient effects on topical drug delivery paper presented at the Industrial Pharmaceutical Technology Section Symposium, 121st Annual Meeting of the American Pharmaceutical Association, Chicago, Abstracts, Vol. 4, p. 24.
71. M. Goodman and B.W. Barry, in Percutaneous Absorption, 2nd ed. (R.L. Bronaugh and H.I. Maibach, eds.), Marcel Dekker, New York, 1989, pp. 567-593.
72. W. Abraham and D.T. Downing, in Prediction of Percutaneous Absorption (R.C. Scott, R.H. Guy, and J. Hadgraft, eds.), IBC Technical Services, London, 1990, pp. 110-122.
73. B.D. Anderson, W.I. Higuchi, and P. Raykar, Pharm. Res., 5, 566 (1988).
74. W.I. Higuchi, W.W. Shannon, J.L. Fox, G.L. Flynn, W.F.H. Ho, R. Vaidyanathan, and D.C. Baker, in Recent Advances in Drug Delivery Systems (J.M. Anderson and S.W. Kim, eds.), Plenum Press, New York, 1984, pp. 1-7.
75. S.Y.E. Hou and G.L. Flynn, Pharm. Res., 3(Suppl.), 525 (1986).
76. G.L. Flynn and N.D. Weiner, in Dermal and Transdermal Delivery-New Insights and Perspectives (R. Gurny, ed.), APV, Stuttgart, 1993, pp. 33-65.
77. M. Goldman, B.J. Poulsen, and T. Higuchi, J. Pharm. Sci., 58, 1098 (1969)
78. B.J. Poulsen, E. Young, V. Coquilla, and M. Katz, J. Pharm. Sci., 57, 928 (1968).
79. V.P. Shah, T.M. Ludden, S.V. Dighe, J.P. Skelly and R.L. Williams, in Topical Drug Bioavailability, Bioequivalence, and Penetration (V.P. Shah and H.I. Maibach, eds.), Plenum Press, New York, 1993, pp. 414-424.
80. L.O. Killings, O. Ringerts, and L. Silverstolpe, Acta Pharm. Suec., 3, 219 (1966).
81. A.A. Fisher, E. Pascher, and N.B. Kanot, Arch. Dermatol., 104, 286 (1971).